Public Health England
London, SE1, United Kingdom
NCT Number: NCT03524131
The National Health Service (NHS) Health Check is a significant part of the strategy to tackle premature mortality and promote healthy lifestyles. Public Health England aspires to an uptake rate of 75% but national uptake is less than 50%. This study aims to assess the impact of two new behaviourally informed NHS Health Check leaflets on the uptake of NHS Health Checks, by randomizing patients in Lewisham and North East Lincolnshire to the different leaflets and comparing patient-level uptake data. The study will test whether a shorter risk-framed leaflet or a shorter benefits-framed leaflet will be more effective than the current national leaflet at encouraging uptake of the NHS Health Check.
Looking for future studies?
Notify Me40 year–74 year
All sexes
Interventional
Not applicable
London, SE1, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2-sided leaflet, emphasizing health risks of not going to the NHS Health Check
2-sided leaflet, emphasizing benefits of attending an NHS Health Check
4-sided leaflet
Time frame: up to 6 months from time of invitation
whether or not the patient attended their NHS Health Check
Public Health England
Other Gov
Randomized Controlled Trial to Compare the Effect of Two New Behaviourally Enhanced NHS Health Check Leaflets and the Current Nationally Recommended Leaflet on Uptake of NHS Health Checks
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04179643
Arrhythmias, Cardiac, Cardiovascular Diseases
Minneapolis, Minnesota, United States
View Trial DetailsNCT07746310
Asthma, Asthma (Diagnosis)
Stockholm, Sweden
View Trial DetailsNCT04040634
Cardiovascular Diseases, Cognition Disorders
Maceió, Alagoas, Brazil
View Trial DetailsNCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial Details